Target intelligence / Profile preview

Tetraspanin-15 (TSPAN15)

Target
TSPAN15
Molecular classification
Tetraspanin family protein, Four-pass transmembrane protein, Partner protein regulator (of metalloproteases)
01

Overview

Tetraspanin-15 (TSPAN15) is a cell-surface protein belonging to the tetraspanin family, characterized by four transmembrane domains, and is a key regulatory subunit of the metalloprotease ADAM10[6][1]. TSPAN15 forms heteromeric complexes with ADAM10, facilitating its exit from the endoplasmic reticulum, trafficking to the cell surface, and defining its substrate specificity[3][1][5]. The TSPAN15–ADAM10 complex acts as a functional "molecular scissor" involved in the proteolytic cleavage of key substrates such as N-cadherin, Notch, and amyloid precursor protein[1][5]. TSPAN15-mediated ADAM10 function is essential in multiple biological processes including cell adhesion, proliferation, migration, and signal transduction[2][6]. TSPAN15 is upregulated in several cancers, where it acts as a marker of poor prognosis and may contribute to tumor progression[1]. Although direct therapeutic targeting has not advanced to clinical-stage drugs, function-blocking monoclonal antibodies to TSPAN15 have been shown experimentally to impair its complex with ADAM10[1].

Other names
Tetraspanin-15TSPAN15NET7TM4SF15UNQ677/PRO1311Tspan-15NET-7Tetraspan NET-7Transmembrane 4 superfamily member 152700063A19Riktetraspan NET-7transmembrane 4 superfamily member tetraspan NET-7
02

Mechanism of action

Monoclonal antibodies impairing function of the ADAM10/TSPAN15 complex through direct inhibition[1]

03

Biological functions

Regulation of ADAM10 maturation, trafficking, and substrate specificitySignal transductionRegulation of cell proliferationRegulation of cell motility and adhesion
04

Disease associations

CancerPoor prognosis marker in certain cancersPotentially other roles in disorders where ADAM10 is key (including neurodegenerative and inflammatory diseases)
05

Safety considerations

Potential on-target toxicity due to widespread tissue expression and crucial roles in development and cell signaling[1]
06

Interacting drugs

Experimental monoclonal antibodies against TSPAN15/ADAM10 complex
07

Biomarkers

Upregulation is a marker of poor prognosis in certain cancers (e.g., referenced as a poor prognostic marker)[1]

Beyond the preview

Go deeper on Tetraspanin-15 (TSPAN15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetraspanin-15 (TSPAN15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call